Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties
Open Access
- 14 July 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (33) , 52928-52939
Abstract
Repurposing the anti-malarial drug, Quinacrine: new anti-colitis propertiesKeywords
This publication has 60 references indexed in Scilit:
- IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cellsJournal of Experimental Medicine, 2012
- A Limited Role of p53 on the Ability of a Hexane Fraction of American Ginseng to Suppress Mouse ColitisJournal of Biomedicine and Biotechnology, 2012
- Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitorAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancersCell Communication and Signaling, 2011
- Inhibition of NF-κB Signaling by Quinacrine Is Cytotoxic to Human Colon Carcinoma Cell Lines and Is Synergistic in Combination with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) or OxaliplatinJournal of Biological Chemistry, 2010
- Resveratrol Suppresses Colitis and Colon Cancer Associated with ColitisCancer Prevention Research, 2010
- American Ginseng Suppresses Colitis through p53-Mediated Apoptosis of Inflammatory CellsCancer Prevention Research, 2010
- Opposing functions of IKKβ during acute and chronic intestinal inflammationProceedings of the National Academy of Sciences, 2008
- American ginseng suppresses inflammation and DNA damage associated with mouse colitisCarcinogenesis, 2008
- Chemically induced mouse models of intestinal inflammationNature Protocols, 2007